youtube_live
Q3 2026: ieņēmumi • pēc 4 dienām
Skatīt detalizētu informācijuchevron_right
AMG:ETR
Amgen Inc
423,05 €
arrow_upward
+2,94%(+12,10) 1 d.
30. okt., 17:35:39 GMT+1 · EUR
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: AMG…
Atvērt
417,85 €
Augsta
423,50 €
Zema
417,85 €
Tirgus kapitalizācija
251,94 mljrd.
Vid. apjoms
543,00
Apjoms
330,00
Augstākā 52 ned.
423,50 €
Zemākā 52 ned.
249,40 €
Darbinieku skaits
32 tūkst.
Atvērt
417,85 €
Augsta
423,50 €
Zema
417,85 €
Tirgus kapitalizācija
251,94 mljrd.
Vid. apjoms
543,00
Apjoms
330,00
Augstākā 52 ned.
423,50 €
Zemākā 52 ned.
249,40 €
Darbinieku skaits
32 tūkst.
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
Seeking Alpha
·
pirms 15 stundām
Amgen: I Have Clear Doubts About This Company Headed Into Earnings - Earnings Preview
Investing.com Nigeria
·
pirms 16 stundām
Amgen stock hits all-time high at 469.02 USD By Investing.com
Yahoo Finance
·
pirms 1 dienas
Amgen (AMGN) Increases Despite Market Slip: Here's What You Need to Know
MarketWatch
·
pirms 1 dienas
Amgen Inc. stock outperforms competitors on strong trading day
Profils
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Par “Amgen Inc”
ĢenerāldirektorsRobert A. Bradway
Darbinieki31,5 tūkst.
Dibināšanas datums1980
Galvenais birojsTauzandoksa, Kalifornija, Amerikas Savienotās Valstis
Sektors-
Tīmekļa vietneamgen.com